Affiliation:
1. Animal Science Laboratory, Orentreich Foundation for the Advancement of Science, 855 Route 301, Cold Spring, NY 10516, USA
Abstract
Nonalcoholic fatty liver disease (NAFLD) is the most common initial presentation of obesity and insulin resistance. Uninterrupted progression of hepatic lipid accumulation often leads to fatty liver disease and eventually cirrhosis. Insulin resistance is one of the characteristics of type 2 diabetes. Several types of treatment have been employed against type 2 diabetes some of which ameliorate NAFLD. The frequent line of treatment to improve insulin sensitivity is the use of thiazolidinediones (TZD) which activate the nuclear receptor, peroxisome proliferator activated receptor gamma (Pparγ). Although TZDs are proven to be very effective in promoting insulin sensitivity, its actions onPparγhave been complicated, specifically on NAFLD. According to studies in different models,Pparγmanifests both beneficial and undesirable effects on NAFLD. This paper will focus on the current knowledge ofPparγand its effect on NAFLD.
Subject
Pharmacology (medical),Drug Discovery
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献